Merck taps five Indian drugmakers to expand COVID-19 drug production
Merck & Co Inc said on Tuesday it had tied up with five generic drugmakers in India to expand access to molnupiravir, an experimental antiviral COVID-19 therapy it is developing with Ridgeback Biotherapeutics.
Read More
Canada’s ex-finance minister breached ethics rules in charity dealings 
Judge axes employee wage claims, keeps others in Wawa data breach case